Stock·NYSE·Consumer Cyclical
Nike, Inc. (NKE)
- Market cap
- $55.79B
- P/E
- 18.06
- Dividend yield
- 4.37%
- Street target
- $34.00median of 42 analysts
- 52-week range
- $31.97 $69.14
NKE stock forecast today
Where NKE stands today, and what CleaRank Financial AI makes of it.
NKE at a glance
Nike, Inc. (NKE): Hold, 48/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 50-day but below its 200-day moving average ($37.09 and $46.47).
- Earnings NKE beat estimates in 8 of its last 8 quarters, yet fell the next day after 5 of those beats.
- Insiders Insiders sold $32.5M and bought $9.2M over the last 18 months.
- Valuation P/E of 18.1 against 20.8 for the Consumer Cyclical sector: broadly in line with peers (-13%).
Figures as of October 27, 2026.
CleaRank Financial AI
Nike, Inc. (NKE) earns a Hold rating from CleaRank, with a model score of 48/100.
Its earnings record gives the score the biggest lift, with estimates beaten in 8 of the last 8 reports and the latest report beating the estimate by 9.09%. The trend is the largest drag: the price is 19.17% below the 200-day average, and the 50-day average is 20.19% below the 200-day. The 50-day average is $37.09 and the 200-day is $46.47. The price fell 45.24% over the past year.
Only on CleaRank
Figures we compute ourselves from NKE's own price, earnings and insider-filing history. Tap one to see it in context.
NKE stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $37.56 is 1.3% above the 50-day simple moving average of $37.09.Price above its 200-day average ›
The price is 19.2% below the 200-day simple moving average of $46.47.50-day average above the 200-day ›
The 50-day average ($37.09) is 20.2% below the 200-day average ($46.47), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 15% of its 52-week range, between $31.97 and $69.14.
NKE share price
Pick a period: each tab shows how far NKE has moved over it, to the last close.
Today's trading
Where NKE sits inside today's range and its 52-week range.
NKE fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 18.06 is 13.2% below the Consumer Cyclical median of 20.8.P/S below the sector median ›
The price-to-sales ratio of 1.23 is 35.4% below the sector median of 1.9.Profitable over the last 12 months ›
Net income over the last 12 months was $3.1B on revenue of $45.9B, a net margin of 6.7%.Beat estimates in most recent reports ›
NKE beat the EPS estimate in 8 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 4.37%, or $1.64 a share a year.
Key statistics
The headline figures for NKE.
As of October 27, 2026, NKE trades at $37.56, with a market value of $55.79B, a P/E ratio of 18.06 and a dividend yield of 4.37%.
What the numbers say
CleaRank Financial AI's reading of NKE's valuation, growth and risks.
Against a Consumer Cyclical median trailing P/E of 20.8, NKE's trailing P/E of 18.06 is 13.2% below that level, and the peer comparison on this page rates the P/E as broadly in line with peers. Measured on sales, the price-to-sales ratio of 1.23 is 35.3% below the sector median of 1.9. Nike, Inc. carries a market capitalisation of $55.8B, and its trailing earnings stand at $2.08 per share.
NKE is growing more slowly than its sector. The company converts sales into a net margin of 6.74% and an operating margin of 7.92%. Return on equity, a measure of how well shareholders' capital is used, comes in at 21.56%, which is above the sector median of 12.4%. On the balance sheet, debt-to-equity stands at 0.73, and the trailing dividend yield is 4.37%, or $1.64 a share each year.
Nike, Inc. (NKE) reported on October 1, 2026 and beat the estimate by 9.09%, posting EPS of $0.48 against the $0.44 analysts had expected. Even so, the stock dropped 3.64% in the following session.
NKE has topped the EPS estimate in all 8 of its recent reports, yet that record has not reliably lifted the shares. The stock fell the session after 5 of those beats. Among the 3 reports before the latest, the biggest reaction followed the March 31, 2026 report: EPS beat the estimate by 25.00%, but the stock dropped 15.51%. Analysts forecast EPS of $1.25 for this fiscal year, a fall of 40.5%, and $1.55 for the year after, a rise of 23.8%.
NKE's price typically moves by 1.73% in a day, based on the 30-day standard deviation of its daily returns, and its beta against the S&P 500 is 1.10. The stock is 45.68% below its 52-week high of $69.14. Over the last 18 months insiders sold $32.5M of stock and bought $9.2M. Insider sales are often planned in advance or made to cover taxes on vesting shares, so they tell less than open-market purchases do.
NKE against the Consumer Cyclical sector
How NKE compares with the median Consumer Cyclical stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (-13% difference), suggesting fair market pricing relative to industry standards.
Return vs SPY: Since May 15, 2025, NKE has lost 39.8% against a gain of 30.4% for SPY.
Performance against SPY
NKE and the S&P 500 (SPY) over the same days.
Revenue and earnings
How much NKE sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to May 31, 2026); NKE reported again on October 1, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 0.2% in FY2026 to $46.4B, from $46.3B a year earlier.
Profit margin: The net margin was 6.7% in FY2026, down from 7.0% the year before.
Profitable: NKE earned $3.1B in FY2026.
Earnings reality check
Did NKE beat what analysts expected, and how did the stock react?
Earnings record: NKE beat the analyst estimate in 8 of the last 8 quarters.
Market reaction: The stock fell in the first session after 5 of those 8 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 1, 2026after close | $0.44 | $0.48 | +9.09% | -3.64% | -1.17% |
| Jun 30, 2026after close | $0.13 | $0.72 | +453.85% | +4.90% | +4.48% |
| Mar 31, 2026after close | $0.28 | $0.35 | +25.00% | -15.51% | -18.35% |
| Dec 18, 2025after close | $0.38 | $0.53 | +39.47% | -10.54% | -7.16% |
| Sep 30, 2025after close | $0.27 | $0.49 | +81.48% | +6.41% | -1.18% |
| Jun 26, 2025after close | $0.12 | $0.14 | +16.67% | +15.19% | +22.15% |
| Mar 20, 2025after close | $0.29 | $0.54 | +86.21% | -5.46% | -8.43% |
| Dec 19, 2024after close | $0.63 | $0.78 | +23.81% | -0.21% | -0.88% |
As of October 27, 2026, NKE has beaten the analyst EPS estimate in 8 of its last 8 reported quarters and fell in the first trading session after 5 of those beats; its latest report, on October 1, 2026, came in 9.09% above the estimate and the stock moved -3.64% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
NKE AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 56.0, in neutral territory.RSI above 50 ›
An RSI of 56.0 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of NKE
The score, the reasoning behind it, and what could move the price next.
Nike, Inc. (NKE) shows a mixed trend. At $37.56, the stock is 1.28% above its 50-day average of $37.09, yet 19.17% below its 200-day average of $46.47. Within its 52-week range, the price sits near the bottom: 17.49% above the low of $31.97, and 45.68% below the high of $69.14.
Recent gains sit on top of a weaker longer record. The price is up 5.06% over the past month, yet it is down 12.75% over three months and down 45.24% over the past year. Last session volume was 41.6% below its average on a day when the price slipped 0.92%. The 14-day RSI of 56.0 sits in the neutral zone, and the MACD line is positive.
Analyst upgrade ›
Freedom Broker upgraded it to Buy from Sell on October 2, 2026.
Source: Analyst action, Freedom Broker, October 2, 2026Rating reaffirmed ›
Barclays kept its Overweight rating on October 5, 2026.
Source: Analyst action, Barclays, October 5, 2026
Earnings beat, but the stock fell ›
The October 1, 2026 report beat the EPS estimate by 9.09%, and the share price fell 3.64% in the first session after it.
Source: Earnings report, October 1, 2026
- The two nearest levels to watch are the 200-day SMA at $46.47, just above the price, and the 50-day SMA at $37.09, just below it.
- The 14-day RSI is 56.0, which places it in the neutral zone, and the MACD line is positive. Readings above 70 or below 30 would signal stretched momentum.
- The share price dropped 3.64% in the first session after the October 1, 2026 report, even though NKE had beaten estimates in 8 of the last 8 reports.
NKE sits in mixed territory: the price is above its 50-day average of $37.09 but under its 200-day average of $46.47. Closing above the 200-day would bring both signals up, while closing below the 50-day would push both down. For now the nearest levels are the 50-day SMA at $37.09 below the price and the 200-day SMA at $46.47 above it.
Technical indicators
Momentum and trend for NKE, from its daily closes.
As of October 27, 2026, with NKE at $37.56, its 14-day RSI is 56.0 (neutral territory), its 50-day simple moving average is $37.09 and its 200-day is $46.47.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What NKE moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, NKE's 1-year correlation of daily returns is +0.37 with S&P 500 (SPY), +0.26 with Nasdaq 100 (QQQ), +0.08 with Bitcoin (BTC) and -0.01 with gold (XAU).
NKE price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
0/3Most analysts rate it a buy ›
10 of 42 analysts rate it a buy or strong buy, 25 a hold and 7 a sell.Median target above the price ›
The median 12-month target of $34.00 is 9.5% below the price.More buy ratings than three months ago ›
10 of 42 rate it a buy now, against 12 of 39 three months ago.
NKE Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 5, 2026 | Barclays | Maintains | Overweight |
| Oct 2, 2026 | Freedom Broker | Upgrade | Buy |
| Oct 2, 2026 | UBS | Maintains | Neutral |
| Oct 2, 2026 | Telsey Advisory Group | Maintains | Market Perform |
| Oct 2, 2026 | Citigroup | Maintains | Neutral |
| Oct 2, 2026 | Morgan Stanley | Maintains | Underweight |
As of October 27, 2026, 42 Wall Street analysts cover NKE: 10 rate it a buy or strong buy, 25 a hold and 7 a sell or strong sell. Their 12-month price targets range from $19.00 to $60.00. The median NKE price target is $34.00, 9.5% below the price of $37.56.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
NKE trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
NKE trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from NKE's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much NKE tends to move, against the market and on its own.
NKE price history and drawdowns
NKE's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 1.73% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 79.1%, from November 2021 to October 2026; the price is still 76.8% below that peak.Most 1-year holds ended higher ›
54% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $8,444, against $42,015 in the S&P 500 (SPY).
NKE Drawdowns & Recovery
As of October 27, 2026, NKE's worst peak-to-trough fall over the last 10 years with dividends reinvested was -79.1% (November 2021 to October 2026); it is still 76.8% below that peak, and 54% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into NKE in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: NKE trailed the S&P 500 over this period: $8,443.94 against $42,015.
A $10,000 investment in NKE in October 2016 would be worth about $8,444 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to NKE, and which have not.
Strongest month, November: an average of +4.40%, up in 8 of 10 years.
Weakest month, March: an average of -6.76%, up in 1 of 10 years.
This month, October: has averaged -0.47%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, NKE's strongest calendar month has been November (average +4.40%, up in 8 of 10 years) and its weakest March (average -6.76%, up in 1 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
NKE stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in NKE, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in NKE today could grow to about $10,545 by 2030 in the base case, with a 90th-percentile outcome near $24,444 and a 10th-percentile outcome around $4,549. The simulation models price only; at today's 4.37% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
NKE Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $39.61 for NKE by 2030 in the base case, from $37.56 today (1.1x over 4 years). The 10th-percentile path ends near $17.09. These are outcomes of a Monte Carlo simulation run on NKE's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $25.00 | $38.06 | $57.95 | |
| 2028 | $21.28 | $38.57 | $69.89 | |
| 2029 | $18.87 | $39.08 | $80.95 | |
| 2030 | $17.09 | $39.61 | $91.81 |
Method: a lognormal simulation of NKE's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
NKE insider trading
What the people running the company have bought and sold.
NKE insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $9.2M on the open market and sold $32.5M.
As of October 27, 2026, NKE insiders reported 19 open-market sales worth $32.5M and 9 open-market purchases worth $9.2M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Alexandre Arnault
Director
|
Grant | 5.2K | - |
| Sep 9, 2026 | Venkatesh Alagirisamy
Chief Operating Officer
|
Sell | 3.7K | $138.0K |
| Sep 9, 2026 | Robert Leinwand
Officer
|
Sell | 3.6K | $137.1K |
| Sep 9, 2026 | Philip Mccartney
Officer
|
Sell | 2.6K | $96.2K |
| Sep 8, 2026 | Timothy D Cook
Director
|
Grant | 5.0K | - |
| Sep 8, 2026 | Thasunda Brown Duckett
Director
|
Grant | 5.0K | - |
| Sep 8, 2026 | Monica Gil
Director
|
Grant | 5.0K | - |
| Sep 8, 2026 | Maria G Henry
Director
|
Grant | 5.0K | - |
| Sep 8, 2026 | Peter B Henry
Director
|
Grant | 5.0K | - |
| Sep 8, 2026 | Travis A Knight
Director
|
Grant | 5.0K | - |
| Sep 8, 2026 | Jorgen Vig Knudstorp
Director
|
Grant | 5.0K | - |
| Sep 8, 2026 | Michelle A Peluso
Director
|
Grant | 5.0K | - |
| Sep 8, 2026 | Robert Holmes Swan
Director
|
Grant | 5.0K | - |
| Sep 1, 2026 | Venkatesh Alagirisamy
Chief Operating Officer
|
Grant | 37.2K | - |
| Sep 1, 2026 | David M Denton
Chief Financial Officer
|
Grant | 71.2K | - |
| Sep 1, 2026 | Treasure Heinle
Officer
|
Grant | 34.1K | - |
| Sep 1, 2026 | Elliott Hill
Chief Executive Officer
|
Grant | 108.4K | - |
| Sep 1, 2026 | Robert Leinwand
Officer
|
Grant | 34.1K | - |
| Sep 1, 2026 | Philip Mccartney
Officer
|
Grant | 31.0K | - |
| Sep 1, 2026 | Amy Montagne
President
|
Grant | 31.0K | - |
| Sep 1, 2026 | Johanna Nielsen
Officer
|
Grant | 11.9K | - |
| Aug 14, 2026 | Mark G Parker
Officer and Director
|
Grant | 11.4K | - |
| Aug 7, 2026 | Amy Montagne
President
|
Sell | 4.9K | $204.7K |
| Aug 5, 2026 | Matthew Friend
Chief Financial Officer
|
Sell | 2.5K | $102.5K |
| Aug 5, 2026 | Venkatesh Alagirisamy
Chief Operating Officer
|
Sell | 890 | $37.0K |
| Aug 5, 2026 | Robert Leinwand
Officer
|
Sell | 821 | $34.2K |
| Aug 5, 2026 | Philip Mccartney
Officer
|
Sell | 524 | $21.8K |
| Jul 30, 2026 | Travis A Knight
Director
|
Grant | 2.9M | - |
| Jun 12, 2026 | Philip Mccartney
Officer
|
Sell | 17.4K | $803.4K |
| May 14, 2026 | Mark G Parker
Officer and Director
|
Grant | 22.2K | - |
| Apr 13, 2026 | Elliott Hill
Chief Executive Officer
|
Buy | 23.7K | $1.0M |
| Apr 13, 2026 | Elliott Hill
Chief Executive Officer
|
Buy | 23.7K | $1.0M |
| Apr 10, 2026 | Timothy D Cook
Director
|
Buy | 25.0K | $1.1M |
| Apr 9, 2026 | John W Rogers Jr
Director
|
Buy | 4.0K | $173.4K |
| Apr 7, 2026 | Robert Holmes Swan
Director
|
Buy | 11.8K | $500.0K |
| Feb 12, 2026 | Robert Leinwand
Officer
|
Sell | 9.1K | $565.0K |
| Feb 11, 2026 | Philip H Knight
Divisional Officer
|
Grant | 4.5M | - |
| Feb 2, 2026 | Philip H Knight
Divisional Officer
|
Grant | 4.5M | - |
| Dec 29, 2025 | Elliott Hill
Chief Executive Officer
|
Buy | 16.4K | $1.0M |
| Dec 22, 2025 | Timothy D Cook
Director
|
Buy | 50.0K | $2.9M |
| Dec 22, 2025 | Robert Holmes Swan
Director
|
Buy | 8.7K | $500.1K |
| Dec 10, 2025 | Venkatesh Alagirisamy
Chief Operating Officer
|
Grant | 36.6K | - |
| Dec 10, 2025 | Matthew Friend
Chief Financial Officer
|
Grant | 31.2K | - |
| Dec 10, 2025 | Treasure Heinle
Officer
|
Grant | 31.2K | - |
| Dec 10, 2025 | Elliott Hill
Chief Executive Officer
|
Grant | 117.1K | - |
| Dec 10, 2025 | Robert Leinwand
Officer
|
Grant | 31.2K | - |
| Dec 10, 2025 | Philip Mccartney
Officer
|
Grant | 31.2K | - |
| Dec 10, 2025 | Amy Montagne
President
|
Grant | 31.2K | - |
| Nov 14, 2025 | Mark G Parker
Officer and Director
|
Sell | 86.1K | $5.6M |
| Nov 14, 2025 | Mark G Parker
Officer and Director
|
Grant | 11.3K | - |
| Nov 7, 2025 | Jorgen Vig Knudstorp
Director
|
Buy | 16.2K | $1.0M |
| Oct 6, 2025 | Treasure Heinle
Officer
|
Sell | 4.3K | $306.5K |
| Oct 2, 2025 | Robert Leinwand
Officer
|
Sell | 697 | $52.4K |
| Sep 9, 2025 | Timothy D Cook
Director
|
Grant | 2.6K | - |
| Sep 9, 2025 | Thasunda Brown Duckett
Director
|
Grant | 2.6K | - |
| Sep 9, 2025 | Monica Gil
Director
|
Grant | 2.6K | - |
| Sep 9, 2025 | Maria G Henry
Director
|
Grant | 2.6K | - |
| Sep 9, 2025 | Peter B Henry
Director
|
Grant | 2.6K | - |
| Sep 9, 2025 | Travis A Knight
Director
|
Grant | 2.6K | - |
| Sep 9, 2025 | Jorgen Vig Knudstorp
Director
|
Grant | 5.2K | - |
| Sep 9, 2025 | Michelle A Peluso
Director
|
Grant | 2.6K | - |
| Sep 9, 2025 | John W Rogers Jr
Director
|
Grant | 2.6K | - |
| Sep 9, 2025 | Robert Holmes Swan
Director
|
Grant | 2.6K | - |
| Sep 5, 2025 | Robert Leinwand
Officer
|
Sell | 1.0K | $76.1K |
| Aug 29, 2025 | Matthew Friend
Chief Financial Officer
|
Grant | 26.2K | - |
| Aug 29, 2025 | Treasure Heinle
Officer
|
Grant | 18.0K | - |
| Aug 29, 2025 | Elliott Hill
Chief Executive Officer
|
Grant | 50.7K | - |
| Aug 29, 2025 | Robert Leinwand
Officer
|
Grant | 18.0K | - |
| Aug 29, 2025 | Philip Mccartney
Officer
|
Grant | 13.7K | - |
| Aug 29, 2025 | Amy Montagne
President
|
Grant | 13.7K | - |
| Aug 29, 2025 | Johanna Nielsen
Officer
|
Grant | 3.1K | - |
| Aug 29, 2025 | Craig Alan Williams
Officer
|
Grant | 26.2K | - |
| Aug 14, 2025 | Mark G Parker
Officer and Director
|
Sell | 86.1K | $6.5M |
| Aug 14, 2025 | Mark G Parker
Officer and Director
|
Grant | 11.3K | - |
| Aug 13, 2025 | Philip Mccartney
Officer
|
Sell | 3.2K | $244.1K |
| Aug 5, 2025 | Robert Leinwand
Officer
|
Sell | 1.6K | $123.2K |
| Jul 16, 2025 | Mark G Parker
Officer and Director
|
Sell | 110.0K | $8.0M |
| Jul 16, 2025 | Mark G Parker
Officer and Director
|
Option | 110.0K | $6.2M |
| May 14, 2025 | Mark G Parker
Officer and Director
|
Sell | 153.0K | $9.5M |
| May 14, 2025 | Mark G Parker
Officer and Director
|
Grant | 11.3K | - |
| May 14, 2025 | Mark G Parker
Officer and Director
|
Option | 110.0K | $6.2M |
Source: TwelveData, from SEC Form 4 filings
NKE stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.